Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial

JACC: Cardiovascular Interventions

Volumn 9, Issue 13, 2016, Pages 1386-1392

  Kinstner, Christian M ^a   Lammer, Johannes ^a   Willfort Ehringer, Andrea ^a   Matzek, Wolfgang ^a   Gschwandtner, Michael ^a   Javor, Domagoj ^a   Funovics, Martin ^a   Schoder, Maria ^a   Koppensteiner, Renate ^a   Loewe, Christian ^a   Ristl, Robin ^a   Wolf, Florian ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

drug eluting balloon; femoropopliteal artery; in stent restenosis; peripheral artery disease

Indexed keywords

ANTIFIBRINOLYTIC AGENT; BIOCOMPATIBLE COATED MATERIAL; CARDIOVASCULAR AGENT; PACLITAXEL;

AGED; ANKLE BRACHIAL INDEX; ARTICLE; ARTIFICIAL EMBOLIZATION; ASPIRATION EMBOLECTOMY; BALLOON; BLEEDING; CARDIOVASCULAR DISEASE ASSESSMENT; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR STENT; CLINICAL OUTCOME; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ELUTING BALLOON; EMBOLECTOMY; FASCIOTOMY; FEMALE; GROIN HEMATOMA; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; MEAN LESION LENGTH; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROXIMAL POPLITEAL ARTERY; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; RUTHERFORD BECKER CATEGORY; SINGLE BLIND PROCEDURE; SUPERFICIAL FEMORAL ARTERY; THROMBOSIS; TIBIAL ARTERY; VASCULAR PATENCY; ADVERSE EFFECTS; AUSTRIA; CLINICAL TRIAL; DEVICES; DIAGNOSTIC IMAGING; EQUIPMENT DESIGN; FEMORAL ARTERY; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; RECURRENT DISEASE; RETREATMENT; RISK FACTOR; STATISTICAL MODEL; STENT; TIME FACTOR; TREATMENT OUTCOME; VASCULAR ACCESS DEVICE;

AGED; ANGIOPLASTY, BALLOON; ANKLE BRACHIAL INDEX; AUSTRIA; CARDIOVASCULAR AGENTS; COATED MATERIALS, BIOCOMPATIBLE; EQUIPMENT DESIGN; FEMALE; FEMORAL ARTERY; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PACLITAXEL; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROSPECTIVE STUDIES; RECURRENCE; RETREATMENT; RISK FACTORS; SINGLE-BLIND METHOD; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES; VASCULAR PATENCY;

EID: 84990855909     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2016.04.012     Document Type: Article

References (26)

1. 1 Schillinger, M., Sabeti, S., Loewe, C., et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354 (2006), 1879–1888.
2. 2 Schillinger, M., Sabeti, S., Dick, P., et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 115 (2007), 2745–2749.
3. 3 Lammer, J., Zeller, T., Hausegger, K.A., et al. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn Endoprosthesis With PROPATEN Bioactive Surface [VIA] Versus Bare Nitinol Stent in the Treatment of Long Lesions in Superficial Femoral Artery Occlusive Disease). J Am Coll Cardiol 62 (2013), 1320–1327.
4. 4 Lammer, J., Zeller, T., Hausegger, K.A., et al. Sustained benefit at 2 years for covered stents versus bare-metal stents in long SFA lesions: the VIASTAR trial. Cardiovasc Intervent Radiol 38 (2015), 25–32.
5. 5 Dick, P., Sabeti, S., Mlekusch, W., et al. Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience. Radiology 248 (2008), 297–302.
6. 6 Tepe, G., Zeller, T., Albrecht, T., et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 358 (2008), 689–699.
7. 7 Werk, M., Langner, S., Reinkensmeier, B., et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation 118 (2008), 1358–1365.
8. 8 Werk, M., Albrecht, T., Meyer, D.R., et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial. Circ Cardiovasc Interv 5 (2012), 831–840.
9. 9 Liistro, F., Grotti, S., Porto, I., et al. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery). J Am Coll Cardiol Intv 6 (2013), 1295–1302.
10. 10 Scheinert, D., Duda, S., Zeller, T., et al. The LEVANT I (Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. J Am Coll Cardiol Intv 7 (2014), 10–19.
11. 11 Scheller, B., Clever, Y.P., Kelsch, B., et al. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. J Am Coll Cardiol Intv 5 (2012), 323–330.
12. 12 Rittger, H., Brachmann, J., Sinha, A.M., et al. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. J Am Coll Cardiol 59 (2012), 1377–1382.
13. 13 Navarese, E.P., Austin, D., Gurbel, P.A., et al. Drug-coated balloons in treatment of in-stent restenosis: a meta-analysis of randomised controlled trials. Clin Res Cardiol 102 (2013), 279–287.
14. 14 Lee, J.M., Park, J., Kang, J., et al. Comparison among drug-eluting balloon, drug-eluting stent, and plain balloon angioplasty for the treatment of in-stent restenosis: a network meta-analysis of 11 randomized, controlled trials. J Am Coll Cardiol Intv 8 (2015), 382–394.
15. 15 Stabile, E., Virga, V., Salemme, L., et al. Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis. J Am Coll Cardiol 60 (2012), 1739–1742.
16. 16 Martin, M.L., Tay, K.H., Flak, B., et al. Multidetector CT angiography of the aortoiliac system and lower extremities: a prospective comparison with digital subtraction angiography. AJR Am J Roentgenol 180 (2003), 1085–1091.
17. 17 Catalano, C., Fraioli, F., Laghi, A., et al. Infrarenal aortic and lower-extremity arterial disease: diagnostic performance of multi-detector row CT angiography. Radiology 231 (2004), 555–563.
18. 18 Schernthaner, R., Stadler, A., Lomoschitz, F., et al. Multidetector CT angiography in the assessment of peripheral arterial occlusive disease: accuracy in detecting the severity, number, and length of stenoses. Eur Radiol 18 (2008), 665–671.
19. 19 Langenberger, H., Schillinger, M., Plank, C., et al. Agreement of duplex ultrasonography vs. computed tomography angiography for evaluation of native and in-stent SFA re-stenosis—findings from a randomized controlled trial. Eur J Radiol 81 (2012), 2265–2269.
20. 20 Tosaka, A., Soga, Y., Iida, O., et al. Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol 59 (2012), 16–23.
21. 21 Liistro, F., Angioli, P., Porto, I., et al. Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR study. J Endovasc Ther 21 (2014), 1–8.
22. 22 Virga, V., Stabile, E., Biamino, G., et al. Drug-eluting balloons for the treatment of the superficial femoral artery in-stent restenosis: 2-year follow-up. J Am Coll Cardiol Intv 7 (2014), 411–415.
23. 23 Zeller, T., Dake, M.D., Tepe, G., et al. Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents. J Am Coll Cardiol Intv 6 (2013), 274–281.
24. 24 Bosiers, M., Deloose, K., Callaert, J., et al. Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trial. J Endovasc Ther 22 (2015), 1–10.
25. 25 Dippel, E.J., Makam, P., Kovach, R., et al. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (Excimer Laser Randomized Controlled Study for Treatment of Femoropopliteal In-Stent Restenosis). J Am Coll Cardiol Intv 8 (2015), 92–101.
26. 26 Laird, J.R. Jr., Yeo, K.K., Rocha-Singh, K., et al. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study. Catheter Cardiovasc Interv 80 (2012), 852–859.